Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis

NCT00147329 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merrimack Pharmaceuticals